Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.

MLA

Ferreira, João Pedro, et al. “Rationale of the FIBROTARGETS Study Designed to Identify Novel Biomarkers of Myocardial Fibrosis.” ESC Heart Failure, vol. 5, no. 1, Feb. 2018, pp. 139–48. EBSCOhost, https://doi.org/10.1002/ehf2.12218.

APA

Ferreira, J. P., Machu, J.-L., Girerd, N., Jaisser, F., Thum, T., Butler, J., González, A., Diez, J., Heymans, S., McDonald, K., Gyöngyösi, M., Firat, H., Rossignol, P., Pizard, A., & Zannad, F. (2018). Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis. ESC Heart Failure, 5(1), 139–148. https://doi.org/10.1002/ehf2.12218

Chicago

Ferreira, João Pedro, Jean-Loup Machu, Nicolas Girerd, Frederic Jaisser, Thomas Thum, Javed Butler, Arantxa González, et al. 2018. “Rationale of the FIBROTARGETS Study Designed to Identify Novel Biomarkers of Myocardial Fibrosis.” ESC Heart Failure 5 (1): 139–48. doi:10.1002/ehf2.12218.